Life Science Compliance Update

November

2017

Why it matters – Pharmaceutical compliance, Anti-corruption and Access to Medicine

Written by , Posted in Uncategorized

Luca Genovese and Danny Edwards, The Access to Medicine Foundation

Access to medicine continues to be out of reach for an estimated two billion people worldwide. While it is clear that corruption plays a role in that problem, the true scope and cost of global health corruption is unknown. This article examines what pharmaceutical companies do and what role they should play in eliminating corruption as part of the equation of ensuring access.


   or   


Gravityscan Badge
Menu Title